In Conversation with Gerard Evan
Overview
Authors
Affiliations
Gerard Evan is Head of Department and Sir William Dunn Professor at the Department of Biochemistry, University of Cambridge, UK. Driven by his innate passion to understand how things work, Gerard has devoted much of his career to understanding the molecular basis of cancer, particularly the roles played by oncogenes such as Myc. His work has helped elucidate the complex role that this gene plays in cell proliferation and apoptosis, and paved new avenues for the treatment of aggressive cancers. In this interview, Gerard provides an overview of what is known about the role of Myc in normal and cancer cells and provides a persuasive argument for the application of 'impersonalised therapy' involving Myc inhibition as part of future chemotherapeutic drug regimes.
Targeting MYC-driven lymphoma: lessons learned and future directions.
Martinez-Martin S, Beaulieu M, Soucek L Cancer Drug Resist. 2023; 6(2):205-222.
PMID: 37457123 PMC: 10344726. DOI: 10.20517/cdr.2022.127.
Warenius H Cancer Rep (Hoboken). 2023; 6(8):e1844.
PMID: 37279947 PMC: 10432422. DOI: 10.1002/cnr2.1844.
MYC inhibitors in multiple myeloma.
Martinez-Martin S, Soucek L Cancer Drug Resist. 2022; 4(4):842-865.
PMID: 35582389 PMC: 8992455. DOI: 10.20517/cdr.2021.55.
Feunteun J, Ostyn P, Delaloge S iScience. 2022; 25(5):104217.
PMID: 35494254 PMC: 9044163. DOI: 10.1016/j.isci.2022.104217.
The Provocative Roles of Platelets in Liver Disease and Cancer.
Kanikarla Marie P, Fowlkes N, Afshar-Kharghan V, Martch S, Sorokin A, Shen J Front Oncol. 2021; 11:643815.
PMID: 34367949 PMC: 8335590. DOI: 10.3389/fonc.2021.643815.